BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30593273)

  • 1. FGFR1 expression defines clinically distinct subtypes in pancreatic cancer.
    Haq F; Sung YN; Park I; Kayani MA; Yousuf F; Hong SM; Ahn SM
    J Transl Med; 2018 Dec; 16(1):374. PubMed ID: 30593273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
    Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
    Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
    Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
    Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
    Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
    Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
    Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
    Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR1 is an adverse outcome indicator for luminal A breast cancers.
    Shi YJ; Tsang JY; Ni YB; Chan SK; Chan KF; Tse GM
    Oncotarget; 2016 Jan; 7(4):5063-73. PubMed ID: 26673008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth.
    Liu Z; Neiss N; Zhou S; Henne-Bruns D; Korc M; Bachem M; Kornmann M
    Cancer Res; 2007 Mar; 67(6):2712-9. PubMed ID: 17363592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
    Tran TN; Selinger CI; Kohonen-Corish MRJ; McCaughan BC; Kennedy CW; O'Toole SA; Cooper WA
    Lung Cancer; 2013 Sep; 81(3):462-467. PubMed ID: 23806793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer.
    Cheng CL; Thike AA; Tan SY; Chua PJ; Bay BH; Tan PH
    Breast Cancer Res Treat; 2015 May; 151(1):99-111. PubMed ID: 25868865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.
    Luo J; Liu S; Leung S; Gru AA; Tao Y; Hoog J; Ho J; Davies SR; Allred DC; Salavaggione AL; Snider J; Mardis ER; Nielsen TO; Ellis MJ
    J Mol Diagn; 2017 Jan; 19(1):147-161. PubMed ID: 27993329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.
    Zhang L; Yu H; Badzio A; Boyle TA; Schildhaus HU; Lu X; Dziadziuszko R; Jassem J; Varella-Garcia M; Heasley LE; Kowalewski AA; Ellison K; Chen G; Zhou C; Hirsch FR
    J Thorac Oncol; 2015 Jul; 10(7):1083-90. PubMed ID: 26020126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.
    Raja A; Malik MFA; Haq F
    PLoS One; 2021; 16(6):e0252344. PubMed ID: 34061869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.
    Lehtinen B; Raita A; Kesseli J; Annala M; Nordfors K; Yli-Harja O; Zhang W; Visakorpi T; Nykter M; Haapasalo H; Granberg KJ
    BMC Cancer; 2017 May; 17(1):310. PubMed ID: 28468611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression.
    Tian X; Chen G; Zhou S; Henne-Bruns D; Bachem M; Kornmann M
    Hepatogastroenterology; 2012; 59(117):1604-8. PubMed ID: 22683979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression.
    Xie G; Ke Q; Ji YZ; Wang AQ; Jing M; Zou LL
    Braz J Med Biol Res; 2018 Nov; 52(1):e7816. PubMed ID: 30484492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.